Evidence map›Paper›PMID 39713770›Full record

ArticleFrontiers in psychiatry2024

Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use.

Jonathan Brett, Elizabeth Knock, Kathy Watson, Steven Albert, Krista J Siefried, Jeffrey Guss

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. The Emergence of Psilocybin in Psychiatry and Neuroscience.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jonathan BrettSt. Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
Elizabeth KnockSt. Vincent's Hospital Alcohol and Drug Service, St. Vincent's Hospital, Sydney, NSW, Australia.
Kathy WatsonSt. Vincent's Hospital Alcohol and Drug Service, St. Vincent's Hospital, Sydney, NSW, Australia.
Steven AlbertSchool of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
Krista J SiefriedSt. Vincent's Hospital Alcohol and Drug Service, St. Vincent's Hospital, Sydney, NSW, Australia.
Jeffrey GussNew York University (NYU) Postdoctoral Program in Psychotherapy and Psychoanalysis, New York University (NYU) Grossman School of Medicine, New York, NY, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methamphetamine (MA) dependence leads to severe physical and psychological issues. Current treatments, including psychosocial therapies and residential rehabilitation, face limitations such as high relapse rates, cost, and accessibility issues. As a result, there is an urgent need for novel approaches to treat MA dependence that are effective, affordable, and accessible to patients. Psilocybin, the active component in numerous mushrooms of the

Indexed as

methamphetamine dependencemethamphetamine use disorderpsilocybinpsychedelicpsychotherapytreatment

Identifiers

PMID39713770
PMCPMC11659228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.